|S-1Jul 27, 8:00 PM ET

SENSUS DRUG DEVELOPMENT CORP S-1

S-1 · SENSUS DRUG DEVELOPMENT CORP · Filed Jul 28, 1998

Documents

24 files
  • S-1
    Primary

    FORM S-1

  • EX-3.1

    AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

  • EX-3.3

    CURRENT BYLAWS OF REGISTRANT

  • EX-3.4

    AMENDED BYLAWS OF REGISTRANT

  • EX-4.2

    AMENDED INVESTORS' RIGHTS AGREEMENT

  • EX-10.1

    REGISTRANT'S 1998 EQUITY INCENTIVE PLAN

  • EX-10.2

    REGISTRANT'S 1998 EMPLOYEE STOCK PLAN

  • EX-10.3

    REGISTRANT'S 1998 NON-EMPLOYEE DIRECTOR'S STOCK

  • EX-10.4

    FORM OF INDEMNIFICATION AGREEMENT

  • EX-10.5

    MANUFACTURING SERVICES ACCOUNT

  • EX-10.6

    LETTER OF INTENT

  • EX-10.7

    LICENSE AGREEMENT WITH GENETECH, INC.

  • EX-10.8

    BIOTECHNOLOGY LICENSING AND TRANSFER AGREEMENT

  • EX-10.9

    CLARIFICATION TO BIOTECHNOLOGY LICENSING

  • EX-10.10

    SUBLICENSE AGREEMENT DATED 7/14/1994

  • EX-10.11

    FIRST AMENDMENT TO SUBLICENSE AGREEMENT

  • EX-10.12

    ASSIGNMENT AND ASSUMPTION AGREEMENT

  • EX-10.13

    AMENDED ASSIGNMENT AND ASSUMPTION AGREEMENT

  • EX-10.14

    SPONSORED RESEARCH AGREEMENT

  • EX-10.15

    AGREEMENT BETWEEN REGISTRANT AND JAVELIN CAPITAL

  • EX-10.16

    BOARD OBSERVER AND VISITATION RIGHTS AGREEMENT

  • EX-10.17

    BOARD OBSERVER, RIGHT OF FIRST REFUSAL

  • EX-23.1

    CONSENT OF ERNST & YOUNG

  • EX-27

    FINANCIAL DATA SCHEDULE